ADMA Biologics Inc (ADMA) - Financial and Strategic SWOT Analysis Review
August 2019
52
About the Report
About the Report
ADMA Biologics Inc (ADMA)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
ADMA Biologics Inc (ADMA Biologics) is an integrated biopharmaceutical and specialty immunoglobulin company which develops, produces, and commercializes specialty biologics to treat immune deficiencies and prevent certain infectious diseases. The company develops RI-002, is a specialty plasma-derived, polyclonal, intravenous immune globulin, derived from human plasma containing naturally occurring polyclonal antibodies to treat Primary Immune Deficiency Disease. ADMA Biologics' target treatment areas include bacterial infections, respiratory syncytial virus and primary immune deficiency diseases. It also operates bio centers which carry out plasma collection and offer blood plasma to manufacture the company's products. ADMA Biologics is headquartered in Ramsey, New Jersey, the US.
ADMA Biologics Inc Key Recent Developments
Aug 08,2019: ADMA Biologics reports second quarter and first half 2019 Financial Results
May 08,2019: ADMA Biologics reports first quarter 2019 financial results
Apr 17,2019: ADMA Biologics granted U.S. patent for treatment and prevention of pneumococcal infections
Mar 13,2019: ADMA Biologics reports full year 2018 financial results
Feb 12,2019: ADMA Biologics enters into USD 72.5 million loan facility with Perceptive Advisors
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
ADMA Biologics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Companies
Shire Plc
Octapharma AG
Kedrion SpA
Grifols Biologicals Inc
GlycoMimetics Inc
Enanta Pharmaceuticals Inc
CSL Behring LLC
Aqua Pharmaceuticals LLC
Anacor Pharmaceuticals Inc
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1-About the Company
ADMA Biologics Inc-Key Facts
ADMA Biologics Inc-Key Employees
ADMA Biologics Inc-Key Employee Biographies
ADMA Biologics Inc-Major Products and Services
ADMA Biologics Inc-History
ADMA Biologics Inc-Company Statement
ADMA Biologics Inc-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2-Company Analysis
Company Overview
ADMA Biologics Inc-Business Description
Product Category: License Revenue
Performance
Product Category: Other revenue
Performance
Product Category: Product Revenue
Performance
Product Category: ADMA BioManufacturing
Overview
Performance
Product Category: Corporate
Performance
Product Category: Plasma Collection Center
Overview
Performance
R&D Overview
ADMA Biologics Inc-Corporate Strategy
ADMA Biologics Inc-SWOT Analysis
SWOT Analysis-Overview
ADMA Biologics Inc-Strengths
ADMA Biologics Inc-Weaknesses
ADMA Biologics Inc-Opportunities
ADMA Biologics Inc-Threats
ADMA Biologics Inc-Key Competitors
Section 3-Company Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Performance Chart
Financial Performance
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Section 4-Company's Lifesciences Financial Deals and Alliances
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
ADMA Biologics Inc, Recent Deals Summary
Section 5-Company's Recent Developments
Aug 08, 2019: ADMA Biologics reports second quarter and first half 2019 Financial Results
May 08, 2019: ADMA Biologics reports first quarter 2019 financial results
Apr 17, 2019: ADMA Biologics granted U.S. patent for treatment and prevention of pneumococcal infections
Mar 13, 2019: ADMA Biologics reports full year 2018 financial results
Feb 12, 2019: ADMA Biologics enters into USD 72.5 million loan facility with Perceptive Advisors
Nov 08, 2018: ADMA Biologics reports third quarter 2018 financial results
Oct 03, 2018: ADMA BioCenters receives FDA approval for third plasma collection center
Aug 10, 2018: ADMA Biologics reports second quarter 2018 financial results
Jul 26, 2018: Adma Biologics reports successful close-out of its April 2018 FDA compliance inspection
May 14, 2018: ADMA Biologics Reports First Quarter 2018 Financial Results
Section 6-Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
ADMA Biologics Inc, Performance Chart (2014-2018)
ADMA Biologics Inc, Ratio Charts
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
List of Table
List of Tables
ADMA Biologics Inc, Key Facts
ADMA Biologics Inc, Key Employees
ADMA Biologics Inc, Key Employee Biographies
ADMA Biologics Inc, Major Products and Services
ADMA Biologics Inc, History
ADMA Biologics Inc, Subsidiaries
ADMA Biologics Inc, Key Competitors
ADMA Biologics Inc, Ratios based on current share price
ADMA Biologics Inc, Annual Ratios
ADMA Biologics Inc, Annual Ratios (Cont...1)
ADMA Biologics Inc, Interim Ratios
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
ADMA Biologics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.